Daan van den Broek

2.7k total citations
87 papers, 1.5k citations indexed

About

Daan van den Broek is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Daan van den Broek has authored 87 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Cancer Research, 44 papers in Pulmonary and Respiratory Medicine and 43 papers in Oncology. Recurrent topics in Daan van den Broek's work include Cancer Genomics and Diagnostics (43 papers), Lung Cancer Treatments and Mutations (32 papers) and Genetic factors in colorectal cancer (16 papers). Daan van den Broek is often cited by papers focused on Cancer Genomics and Diagnostics (43 papers), Lung Cancer Treatments and Mutations (32 papers) and Genetic factors in colorectal cancer (16 papers). Daan van den Broek collaborates with scholars based in Netherlands, United States and United Kingdom. Daan van den Broek's co-authors include Guido V. Bloemberg, Ben Lugtenberg, Thomas F. C. Chin‐A‐Woeng, Huub H. van Rossum, Jos H. Beijnen, Gerrit A. Meijer, Rob J. Kraaijenhagen, Remond J.A. Fijneman, Koen M. G. M. van der Drift and Michel M. van den Heuvel and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Daan van den Broek

84 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daan van den Broek Netherlands	22	502	494	476	426	202	87	1.5k
Yu Sun China	20	553 1.1×	456 0.9×	311 0.7×	380 0.9×	94 0.5×	93	1.5k
Adrian Wan Canada	12	245 0.5×	630 1.3×	556 1.2×	169 0.4×	115 0.6×	13	1.2k
Yan Jia China	25	405 0.8×	1.0k 2.1×	354 0.7×	226 0.5×	96 0.5×	89	1.8k
Kevin J. Wu United States	19	218 0.4×	1.1k 2.2×	435 0.9×	456 1.1×	277 1.4×	51	1.8k
Lisa Haley United States	18	290 0.6×	526 1.1×	186 0.4×	207 0.5×	334 1.7×	39	1.1k
Florence Le Calvez‐Kelm France	25	783 1.6×	1.3k 2.6×	820 1.7×	453 1.1×	111 0.5×	68	2.4k
Virote Sriuranpong Thailand	21	1.1k 2.1×	995 2.0×	477 1.0×	381 0.9×	64 0.3×	77	2.2k
Purva Gopal United States	25	502 1.0×	562 1.1×	299 0.6×	212 0.5×	42 0.2×	92	2.3k
Riku Katainen Finland	18	280 0.6×	618 1.3×	287 0.6×	189 0.4×	48 0.2×	33	1.6k
Xuan Bich Trinh Belgium	22	533 1.1×	618 1.3×	380 0.8×	184 0.4×	49 0.2×	39	1.4k

Countries citing papers authored by Daan van den Broek

Since Specialization

Citations

This map shows the geographic impact of Daan van den Broek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daan van den Broek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daan van den Broek more than expected).

Fields of papers citing papers by Daan van den Broek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daan van den Broek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daan van den Broek. The network helps show where Daan van den Broek may publish in the future.

Co-authorship network of co-authors of Daan van den Broek

This figure shows the co-authorship network connecting the top 25 collaborators of Daan van den Broek. A scholar is included among the top collaborators of Daan van den Broek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daan van den Broek. Daan van den Broek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Broek, Daan van den, Gerrit A. Meijer, Iñaki Gutiérrez‐Ibarluzea, et al.. (2025). Towards Recommendations for Cost-Effectiveness Analysis of Predictive, Prognostic, and Serial Biomarker Tests in Oncology. PharmacoEconomics. 43(5). 483–497. 3 indexed citations

Smith, Christopher G., Koen J. Hartemink, Robert C. Rintoul, et al.. (2025). Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study. PLoS Medicine. 22(4). e1004574–e1004574. 2 indexed citations

Monkhorst, Kim, Gabe S. Sonke, Annegien Broeks, et al.. (2025). Divergence of DNA tumor mutations in cerebrospinal fluid in metastatic breast cancer patients with leptomeningeal metastases. The Breast. 85. 104674–104674.

Greuter, Marjolein J.E., Geraldine R. Vink, Jillian Phallen, et al.. (2024). Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer. Therapeutic Advances in Medical Oncology. 16. 12710900–12710900. 11 indexed citations

Laan, P.H. van der, Winette T.A. van der Graaf, Daan van den Broek, et al.. (2024). Interleukin-6 in relation to early recurrence in primary, localized soft tissue sarcoma: An addition for existing risk classification systems?. European Journal of Surgical Oncology. 50(9). 108530–108530. 1 indexed citations

Schouten, Robert D., Vincent van der Noort, Ronald Damhuis, et al.. (2024). Optimising primary molecular profiling in non-small cell lung cancer. PLoS ONE. 19(7). e0290939–e0290939. 1 indexed citations

Sistermans, Erik A., Hugo M. Horlings, Constantijne H. Mom, et al.. (2024). Evaluating the effectiveness of pre-operative diagnosis of ovarian cancer using minimally invasive liquid biopsies by combining serum human epididymis protein 4 and cell-free DNA in patients with an ovarian mass. International Journal of Gynecological Cancer. 34(5). 713–721. 3 indexed citations

Hoeijmakers, Lianne, Marta López‐Yurda, Lindsay G. Grijpink-Ongering, et al.. (2023). 1112P Five-year survival after intermittent targeted therapy and anti-PD1 in stage IV melanoma: An update of the IMPemBra trial. Annals of Oncology. 34. S670–S670. 1 indexed citations

Broek, Daan van den & Harry J.M. Groen. (2023). Screening approaches for lung cancer by blood-based biomarkers: Challenges and opportunities. Tumor Biology. 46(s1). S65–S80. 4 indexed citations

10.

Muller, Mirte, Myron G. Best, Vincent van der Noort, et al.. (2023). Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancer. Tumor Biology. 46(s1). S327–S340. 1 indexed citations

11.

Wekken, Anthonie J. van der, Marthe S. Paats, Lizza Hendriks, et al.. (2023). A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion–positive non–small cell lung cancer. Cancer. 130(5). 683–691. 4 indexed citations

12.

Broek, Daan van den, Iris van ’t Erve, Gerrit A. Meijer, et al.. (2023). A scenario‐drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology. Molecular Oncology. 18(11). 2730–2742. 4 indexed citations

13.

Liefaard, Marte C., Kat Moore, Lennart Mulder, et al.. (2023). Tumour-educated platelets for breast cancer detection: biological and technical insights. British Journal of Cancer. 128(8). 1572–1581. 14 indexed citations

14.

Langen, Adrianus J. de, Kim Monkhorst, Mirjam C. Boelens, et al.. (2023). Trastuzumab-Emtansine and Osimertinib Combination Therapy to Target HER2 Bypass Track Resistance in EGFR Mutation-Positive NSCLC. JTO Clinical and Research Reports. 4(4). 100481–100481. 19 indexed citations

15.

Koole, Simone N., Robert D. Schouten, Koen Degeling, et al.. (2022). Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance. Cancers. 14(7). 1783–1783. 5 indexed citations

16.

Schuuring, Ed, Paul van der Leest, Maartje J. Geerlings, et al.. (2022). A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice. Journal of Molecular Diagnostics. 25(1). 36–45. 18 indexed citations

17.

Schouten, Robert D., Linda J.W. Bosch, Nicole P. Barlo, et al.. (2021). Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non–Small-Cell Lung Cancer. JCO Precision Oncology. 5(5). 1112–1121. 9 indexed citations

18.

Olsen, Maria, et al.. (2021). The diagnostic accuracy of human epididymis protein 4 (HE4) for discriminating between benign and malignant pelvic masses: a systematic review and meta‐analysis. Acta Obstetricia Et Gynecologica Scandinavica. 100(10). 1788–1799. 14 indexed citations

19.

Bussel, Mark T. J. van, Dick Pluim, Bojana Milojkovic Kerklaan, et al.. (2020). Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases. Neurology. 94(5). e521–e528. 51 indexed citations

20.

Heinhuis, Kimberley M., Sjors G. J. G. In ‘t Veld, Daan van den Broek, et al.. (2020). RNA-Sequencing of Tumor-Educated Platelets, a Novel Biomarker for Blood-Based Sarcoma Diagnostics. Cancers. 12(6). 1372–1372. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact